Comparison

(S)-LY3177833 hydrate European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 50 mg
Item no. HY-143430A-50mg
CASRN 2733342-93-1
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
(S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity[1].
Shipping
Room temperature
Manufacturers Applications
Cancer-Kinase/protease
Molecular Weight
327.31
Clinical Information
No Development Reported
Solubility
10 mM in DMSO
Isoform
CDC
Pathway
Cell Cycle/DNA Damage
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close